20250228966. Lipid Nanoparticle (CAPSTAN THERAPEUTICS, .)
LIPID NANOPARTICLE FORMULATIONS AND COMPOSITIONS
Abstract: disclosed are compositions of lipid nanoparticles (lnp) comprising an ionizable cationic lipid, a phospholipid, a sterol, and a peg-lipid (non-functionalized and optionally functionalized). the functionalized peg-lipid can be conjugated with a binding moiety to create a targeted lnp (tlnp). the disclosed tlnp preferentially deliver a nucleic acid molecule or other negatively charged payload to cells expressing a cell surface antigen recognized by the binding moiety of the tlnp, and are better tolerated, as compared to lnps and tlnps comprising ionizable cationic lipids found in marketed pharmaceuticals comprising lnps.
Inventor(s): Priya Prakash KARMALI, Steven TANIS, Yanjie BAO
CPC Classification: A61K48/0033 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy)
Search for rejections for patent application number 20250228966